Related Experiment Videos
Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma
Urology
|November 1, 1986
Abstract:
This prospective randomized study in nonhormonally responsive adenocarcinoma of the prostate shows that response rates to melphalan vs cyclophosphamide groups were virtually identical.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rotator cuff outcomes and mental health indices: Correlation or causation?
Shoulder & elbow·2023
Interstitial Granulomatous Drug Reaction to Ustekinumab.
Case reports in dermatological medicine·2022
Disseminated protothecosis with central nervous system involvement in a dog in New Zealand.
New Zealand veterinary journal·2022
Efficacy and Safety of Focal and Multifocal Cryoballoon Ablation for Barrett's Esophagus: A Systematic Review and Meta-analysis.
Endoscopy international open·2026
Cuproptosis and anti-tumor immunity: bidirectional regulation, controversies, and translational prospects.
Frontiers in immunology·2026
Multiple relapses of cryptogenic organizing pneumonia: A case report.
Experimental and therapeutic medicine·2026